Cambiar Investors LLC Charles River Laboratories International, Inc. Transaction History

Cambiar Investors LLC

$2.47 Billion
Q3 2024

A detailed history of Cambiar Investors LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cambiar Investors LLC holds 45,930 shares of CRL stock, worth $8.72 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

45,930

Previous 45,436 1.09%

Holding current value

$8.72 Million

Previous $9.39 Million 3.61%

% of portfolio

0.37%

Previous 0.38%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$187.96 - $245.29 $92,852 - $121,173	494 Added 1.09%	45,930 $9.05 Million
Q2 2024 Jul 26, 2024	BUY	$206.39 - $268.73 $65,219 - $84,918	316 Added 0.7%	45,436 $9.39 Million
Q1 2024 May 02, 2024	SELL	$203.52 - $273.43 $3.07 Million - $4.13 Million	-15,093 Reduced 25.07%	45,120 $12.2 Million
Q4 2023 Jan 25, 2024	BUY	$164.52 - $238.84 $1.59 Million - $2.31 Million	9,651 Added 19.09%	60,213 $14.2 Million
Q3 2023 Oct 30, 2023	BUY	$194.44 - $217.61 $352,130 - $394,091	1,811 Added 3.71%	50,562 $9.91 Million
Q2 2023 Jul 31, 2023	BUY	$183.71 - $210.25 $1.04 Million - $1.19 Million	5,664 Added 13.15%	48,751 $10.2 Million
Q1 2023 May 08, 2023	BUY	$191.89 - $259.92 $1.65 Million - $2.24 Million	8,607 Added 24.96%	43,087 $8.7 Million
Q4 2022 Feb 02, 2023	BUY	$197.11 - $250.07 $470,501 - $596,917	2,387 Added 7.44%	34,480 $7.51 Million
Q3 2022 Oct 28, 2022	BUY	$182.44 - $250.54 $172,953 - $237,511	948 Added 3.04%	32,093 $6.32 Million
Q2 2022 Aug 05, 2022	SELL	$204.13 - $302.4 $72,466 - $107,351	-355 Reduced 1.13%	31,145 $6.66 Million
Q1 2022 Apr 28, 2022	BUY	$255.51 - $362.11 $8.05 Million - $11.4 Million	31,500 New	31,500 $8.95 Million
Q2 2021 Aug 02, 2021	SELL	$294.17 - $371.65 $6.67 Million - $8.42 Million	-22,661 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$249.67 - $299.48 $728,786 - $874,182	2,919 Added 14.79%	22,661 $6.57 Million
Q4 2020 Feb 03, 2021	SELL	$222.0 - $252.62 $1.01 Million - $1.15 Million	-4,537 Reduced 18.69%	19,742 $4.93 Million
Q3 2020 Oct 21, 2020	SELL	$175.56 - $226.45 $540,022 - $696,560	-3,076 Reduced 11.24%	24,279 $5.5 Million
Q2 2020 Aug 03, 2020	SELL	$118.84 - $189.72 $607,272 - $969,469	-5,110 Reduced 15.74%	27,355 $4.77 Million
Q1 2020 Apr 30, 2020	BUY	$98.9 - $178.34 $3.21 Million - $5.79 Million	32,465 New	32,465 $4.1 Million

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.65B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cambiar Investors LLC with notifications on news.

Account

Cambiar Investors LLC Charles River Laboratories International, Inc. Transaction History